{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:42:16Z","timestamp":1761986536884,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stallergenes\/Greer"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.iac.2019.09.002","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T17:06:38Z","timestamp":1573059998000},"page":"59-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Venom Immunotherapy"],"prefix":"10.1016","volume":"40","author":[{"given":"David B.K.","family":"Golden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2019.09.002_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/all.13077","article-title":"Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.002_bib2","series-title":"Middleton's allergy: principles and practice","first-page":"1260","article-title":"Insect allergy","author":"Golden","year":"2014"},{"key":"10.1016\/j.iac.2019.09.002_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2016.10.031","article-title":"Stinging insect hypersensitivity: a practice parameter update 2016","volume":"118","author":"Golden","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib4","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/all.13262","article-title":"EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy","volume":"73","author":"Sturm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.002_bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaci.2005.12.1313","article-title":"Clinical and entomological factors influence the outcome of sting challenge studies","volume":"117","author":"Golden","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0091-6749(05)80012-0","article-title":"Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions","volume":"90","author":"Reisman","year":"1992","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase. A study of the EAACI Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa022952","article-title":"Outcomes of allergy to insect stings in children with and without venom immunotherapy","volume":"351","author":"Golden","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2019.09.002_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-3476(95)70543-0","article-title":"Subsequent insect stings in children with hypersensitivity to Hymenoptera","volume":"126","author":"Hauk","year":"1995","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.iac.2019.09.002_bib10","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaci.2009.03.017","article-title":"Venom immunotherapy reduces large local reactions to insect stings","volume":"123","author":"Golden","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jama.1989.03430020082033","article-title":"Epidemiology of insect venom sensitivity","volume":"262","author":"Golden","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.iac.2019.09.002_bib12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0091-6749(97)70135-0","article-title":"Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial","volume":"100","author":"Brockow","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1067\/mai.2001.111852","article-title":"Premedication with antihistamines may enhance efficacy of specific allergen immunotherapy","volume":"107","author":"Muller","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaci.2008.08.007","article-title":"Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy","volume":"122","author":"Muller","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000103225","article-title":"Premedication with montelukast reduces large local reactions of allergen immunotherapy","volume":"144","author":"Wohrl","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1081-1206(10)61689-4","article-title":"Rush venom immunotherapy in patients experiencing recurrent systemic reactions to conventional venom immunotherapy","volume":"91","author":"Goldberg","year":"2003","journal-title":"Ann Allergy"},{"key":"10.1016\/j.iac.2019.09.002_bib17","first-page":"225","article-title":"Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment with omalizumab","volume":"19","author":"Galera","year":"2009","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1398-9995.2007.01604.x","article-title":"High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis","volume":"63","author":"Kontou-Fili","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.002_bib19","first-page":"225","article-title":"Failure of omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy","volume":"18","author":"Gomis","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.iac.2014.02.004","article-title":"Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients","volume":"34","author":"Niedoszytko","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.iac.2019.09.002_bib21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-92-5-620","article-title":"Regimens of Hymenoptera venom immunotherapy","volume":"92","author":"Golden","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.iac.2019.09.002_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaci.2009.05.026","article-title":"The safety of initiating Hymenoptera immunotherapy at 1 microgram of venom extract","volume":"124","author":"Roumana","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM197807272990401","article-title":"A\u00a0controlled trial of immunotherapy in insect hypersensitivity","volume":"299","author":"Hunt","year":"1978","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2019.09.002_bib24","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaip.2018.09.005","article-title":"Initiating yellow jacket venom immunotherapy with a 100 mcg dose: a challenge?","volume":"7","author":"Vos","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.002_bib25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0091-6749(81)90082-8","article-title":"Dose dependence of Hymenoptera venom immunotherapy","volume":"67","author":"Golden","year":"1981","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib26","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0091-6749(92)90304-K","article-title":"Venom immunotherapy: 10 years of experience with administration of single venoms and 50 micrograms maintenance dose","volume":"89","author":"Reisman","year":"1992","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2010.07.031","article-title":"Honeybee venom immunotherapy in children using a 50-mcg maintenance dose","volume":"127","author":"Houliston","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1399-3038.2010.01137.x","article-title":"A\u00a05-year venom immunotherapy protocol with 50 mcg maintenance dose: safety and efficacy in school children","volume":"22","author":"Konstantinou","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1067\/mai.2001.119154","article-title":"Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses","volume":"108","author":"Rueff","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-6749(91)90095-6","article-title":"Clinical and immunologic follow-up of patients who stop venom immunotherapy","volume":"88","author":"Keating","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0091-6749(98)70167-8","article-title":"Long-term protection after stopping venom immunotherapy","volume":"101","author":"Lerch","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0091-6749(00)90092-7","article-title":"Survey of patients after discontinuing venom immunotherapy","volume":"105","author":"Golden","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jaip.2016.12.031","article-title":"Rush venom immunotherapy: ready for prime time?","volume":"5","author":"Golden","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.002_bib34","first-page":"423","article-title":"Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis","volume":"73","author":"Bernstein","year":"1994","journal-title":"Ann Allergy"},{"key":"10.1016\/j.iac.2019.09.002_bib35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaip.2016.10.011","article-title":"Rush venom immunotherapy in children","volume":"5","author":"Confino-Cohen","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.002_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000322258","article-title":"Three days rush venom immunotherapy in bee allergy: safe, inexpensive, and instantaneously effective","volume":"156","author":"Goldberg","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jaci.2012.02.022","article-title":"Ultrarush versus semirush initiation of insect venom immunotherapy: a randomized controlled trial","volume":"130","author":"Brown","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0091-6749(93)90007-3","article-title":"Selection of Hymenoptera venoms for immunotherapy based on patients' IgE antibody cross-reactivity","volume":"92","author":"Hamilton","year":"1993","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib39","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1398-9995.2012.02847.x","article-title":"IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from cross reaction in venom allergy","volume":"67","author":"Muller","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.002_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1067\/mai.2002.125827","article-title":"Venom immunotherapy improves health-related quality of life in yellow jacket\u00a0allergic patients","volume":"110","author":"Oude-Elberink","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaci.2006.03.049","article-title":"Analysis of the burden of treatment in patients receiving an Epi-Pen for yellow jacket anaphylaxis","volume":"118","author":"Oude-Elberink","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/cea.12275","article-title":"Predictors of clinical effectiveness of Hymenoptera venom immunotherapy","volume":"44","author":"Rueff","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.002_bib44","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cea.12276","article-title":"Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase","volume":"44","author":"Stoevesandt","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.002_bib45","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2012.03.024","article-title":"Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria\/angioedema","volume":"130","author":"Stoevesandt","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.002_bib46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","article-title":"Anaphylaxis: a practice parameter update 2015","volume":"115","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:42:40Z","timestamp":1760179360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856119300645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0889856119300645"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.002","relation":{},"ISSN":["0889-8561"],"issn-type":[{"type":"print","value":"0889-8561"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venom Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}